Despite Mirati Therapeutics Inc. [MRTX]’s great opportunity, the stock is a bit overvalued
In yesterday’s Wall Street session, Mirati Therapeutics Inc. (NASDAQ:MRTX) shares traded at $39.20, up 5.95% from the previous session. 20 analysts cover Mirati Therapeutics Inc. (NASDAQ:MRTX), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $91.00 and a […]
Is Mirati Therapeutics Inc. (NASDAQ:MRTX) being unfairly punished by investors?
In yesterday’s Wall Street session, Mirati Therapeutics Inc. (NASDAQ:MRTX) shares traded at $30.02, down -0.83% from the previous session. 18 analysts cover Mirati Therapeutics Inc. (NASDAQ:MRTX), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $95.00 and a […]
